ginsenoside R2
Internal ID | 316e14c0-1967-44d4-81bf-580bc775f696 |
Taxonomy | Lipids and lipid-like molecules > Prenol lipids > Terpene glycosides > Triterpene glycosides > Triterpene saponins |
IUPAC Name | [(2R,3S,4S,5R,6R)-6-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(2S,5S)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-3,4-dihydroxy-5-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]methyl acetate |
SMILES (Canonical) | CC(=O)OCC1C(C(C(C(O1)OC2CC3(C(CC(C4C3(CCC4C5(CCC(O5)C(C)(C)O)C)C)O)C6(C2C(C(CC6)O)(C)C)C)C)OC7C(C(C(CO7)O)O)O)O)O |
SMILES (Isomeric) | CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O[C@H]2C[C@@]3([C@H](C[C@H]([C@H]4[C@]3(CC[C@@H]4[C@@]5(CC[C@H](O5)C(C)(C)O)C)C)O)[C@@]6([C@@H]2C([C@H](CC6)O)(C)C)C)C)O[C@H]7[C@@H]([C@H]([C@@H](CO7)O)O)O)O)O |
InChI | InChI=1S/C43H72O15/c1-20(44)53-19-25-31(49)32(50)34(57-36-33(51)30(48)23(46)18-54-36)37(56-25)55-24-17-42(8)26(40(6)13-11-27(47)38(2,3)35(24)40)16-22(45)29-21(10-14-41(29,42)7)43(9)15-12-28(58-43)39(4,5)52/h21-37,45-52H,10-19H2,1-9H3/t21-,22+,23+,24-,25+,26+,27-,28-,29-,30-,31+,32-,33+,34+,35-,36-,37+,40+,41+,42+,43-/m0/s1 |
InChI Key | URPKGNJHPFKECW-MCQXXECASA-N |
Popularity | 4 references in papers |
Molecular Formula | C43H72O15 |
Molecular Weight | 829.00 g/mol |
Exact Mass | 828.48712159 g/mol |
Topological Polar Surface Area (TPSA) | 234.00 Ų |
XlogP | 1.50 |
Atomic LogP (AlogP) | 1.54 |
H-Bond Acceptor | 15 |
H-Bond Donor | 8 |
Rotatable Bonds | 8 |
Vina-Ginsenoside R2 |
CHEMBL448234 |
(24S)-6alpha-(2-O-beta-D-Xylopyranosyl-6-O-acetyl-beta-D-glucopyranosyloxy)-20,24-epoxydammarane-3beta,12beta,25-triol |
Target | Value | Probability (raw) | Probability (%) |
---|---|---|---|
Human Intestinal Absorption | + | 0.7680 | 76.80% |
Caco-2 | - | 0.8818 | 88.18% |
Blood Brain Barrier | - | 0.7250 | 72.50% |
Human oral bioavailability | - | 0.8143 | 81.43% |
Subcellular localzation | Mitochondria | 0.8310 | 83.10% |
OATP2B1 inhibitior | - | 0.8726 | 87.26% |
OATP1B1 inhibitior | + | 0.8402 | 84.02% |
OATP1B3 inhibitior | + | 0.9262 | 92.62% |
MATE1 inhibitior | - | 1.0000 | 100.00% |
OCT2 inhibitior | - | 0.7787 | 77.87% |
BSEP inhibitior | + | 0.6447 | 64.47% |
P-glycoprotein inhibitior | + | 0.7717 | 77.17% |
P-glycoprotein substrate | + | 0.5694 | 56.94% |
CYP3A4 substrate | + | 0.7614 | 76.14% |
CYP2C9 substrate | - | 1.0000 | 100.00% |
CYP2D6 substrate | - | 0.8916 | 89.16% |
CYP3A4 inhibition | - | 0.9121 | 91.21% |
CYP2C9 inhibition | - | 0.8786 | 87.86% |
CYP2C19 inhibition | - | 0.8892 | 88.92% |
CYP2D6 inhibition | - | 0.9528 | 95.28% |
CYP1A2 inhibition | - | 0.9380 | 93.80% |
CYP2C8 inhibition | + | 0.7204 | 72.04% |
CYP inhibitory promiscuity | - | 0.9541 | 95.41% |
UGT catelyzed | + | 0.9000 | 90.00% |
Carcinogenicity (binary) | - | 1.0000 | 100.00% |
Carcinogenicity (trinary) | Non-required | 0.6306 | 63.06% |
Eye corrosion | - | 0.9905 | 99.05% |
Eye irritation | - | 0.9066 | 90.66% |
Skin irritation | - | 0.6817 | 68.17% |
Skin corrosion | - | 0.9454 | 94.54% |
Ames mutagenesis | - | 0.6200 | 62.00% |
Human Ether-a-go-go-Related Gene inhibition | + | 0.6824 | 68.24% |
Micronuclear | - | 0.8600 | 86.00% |
Hepatotoxicity | - | 0.6625 | 66.25% |
skin sensitisation | - | 0.9252 | 92.52% |
Respiratory toxicity | + | 0.7222 | 72.22% |
Reproductive toxicity | + | 0.7333 | 73.33% |
Mitochondrial toxicity | + | 0.5500 | 55.00% |
Nephrotoxicity | - | 0.9260 | 92.60% |
Acute Oral Toxicity (c) | I | 0.7505 | 75.05% |
Estrogen receptor binding | + | 0.6823 | 68.23% |
Androgen receptor binding | + | 0.7231 | 72.31% |
Thyroid receptor binding | - | 0.6054 | 60.54% |
Glucocorticoid receptor binding | + | 0.7008 | 70.08% |
Aromatase binding | + | 0.6741 | 67.41% |
PPAR gamma | + | 0.7428 | 74.28% |
Honey bee toxicity | - | 0.6033 | 60.33% |
Biodegradation | - | 0.6750 | 67.50% |
Crustacea aquatic toxicity | + | 0.5800 | 58.00% |
Fish aquatic toxicity | + | 0.9354 | 93.54% |
Proven Targets:
CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
---|---|---|---|---|---|
No proven targets yet! |
Predicted Targets (via Super-PRED):
CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
---|---|---|---|---|
CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 99.18% | 97.25% |
CHEMBL1914 | P06276 | Butyrylcholinesterase | 98.40% | 95.00% |
CHEMBL218 | P21554 | Cannabinoid CB1 receptor | 97.76% | 96.61% |
CHEMBL4303 | P08238 | Heat shock protein HSP 90-beta | 97.62% | 96.77% |
CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 97.36% | 96.09% |
CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 95.20% | 91.11% |
CHEMBL4657 | Q6V1X1 | Dipeptidyl peptidase VIII | 95.00% | 97.21% |
CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 92.57% | 94.45% |
CHEMBL3137262 | O60341 | LSD1/CoREST complex | 91.72% | 97.09% |
CHEMBL1871 | P10275 | Androgen Receptor | 90.71% | 96.43% |
CHEMBL4793 | Q86TI2 | Dipeptidyl peptidase IX | 90.67% | 96.95% |
CHEMBL2179 | P04062 | Beta-glucocerebrosidase | 90.33% | 85.31% |
CHEMBL226 | P30542 | Adenosine A1 receptor | 90.17% | 95.93% |
CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 89.91% | 95.50% |
CHEMBL5888 | Q99558 | Mitogen-activated protein kinase kinase kinase 14 | 89.79% | 100.00% |
CHEMBL1994 | P08235 | Mineralocorticoid receptor | 89.69% | 100.00% |
CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 89.56% | 85.14% |
CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 88.24% | 86.33% |
CHEMBL6136 | O60341 | Lysine-specific histone demethylase 1 | 87.91% | 95.58% |
CHEMBL5255 | O00206 | Toll-like receptor 4 | 87.80% | 92.50% |
CHEMBL4681 | P42330 | Aldo-keto-reductase family 1 member C3 | 87.01% | 89.05% |
CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 86.00% | 96.90% |
CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 85.42% | 89.00% |
CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 85.40% | 95.89% |
CHEMBL340 | P08684 | Cytochrome P450 3A4 | 84.73% | 91.19% |
CHEMBL3922 | P50579 | Methionine aminopeptidase 2 | 84.25% | 97.28% |
CHEMBL3713062 | P10646 | Tissue factor pathway inhibitor | 84.17% | 97.33% |
CHEMBL2635 | P51452 | Dual specificity protein phosphatase 3 | 83.49% | 94.00% |
CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 83.49% | 95.89% |
CHEMBL259 | P32245 | Melanocortin receptor 4 | 83.35% | 95.38% |
CHEMBL5028 | O14672 | ADAM10 | 82.56% | 97.50% |
CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 82.45% | 82.69% |
CHEMBL5957 | P21589 | 5'-nucleotidase | 81.84% | 97.78% |
CHEMBL2842 | P42345 | Serine/threonine-protein kinase mTOR | 81.78% | 92.78% |
CHEMBL2111367 | P27986 | PI3-kinase p110-alpha/p85-alpha | 81.50% | 94.33% |
CHEMBL4618 | P09960 | Leukotriene A4 hydrolase | 80.55% | 97.86% |
CHEMBL4227 | P25090 | Lipoxin A4 receptor | 80.48% | 100.00% |
CHEMBL1293316 | Q9HBX9 | Relaxin receptor 1 | 80.35% | 82.50% |
CHEMBL1075162 | Q13304 | Uracil nucleotide/cysteinyl leukotriene receptor | 80.17% | 80.33% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
Panax japonicus |
Panax vietnamensis |
PubChem | 44593678 |
NPASS | NPC203434 |
LOTUS | LTS0163317 |
wikiData | Q105277934 |